Financial Statements · Financial Reporting
Novo Nordisk Estonia OÜ
Official identifier 16722379Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 2 Jun 2026
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 12,117,439 |
| Balance sheet | Cash and cash equivalents | 145,606 |
| Balance sheet | Current assets | 12,117,439 |
| Balance sheet | Current liabilities | 9,253,790 |
| Balance sheet | Equity | 2,796,885 |
| Balance sheet | Share capital at nominal value | 200,000 |
| Balance sheet | Non-current liabilities | 66,764 |
| Balance sheet | Retained earnings (loss) from previous periods | 1,230,185 |
| Income statement scheme 1 | Labour costs | -2,262,968 |
| Income statement scheme 1 | Revenue | 37,002,060 |
| Income statement scheme 1 | Annual period profit / loss | 1,366,700 |
| Income statement scheme 1 | Operating profit (loss) | 1,286,474 |
| Income statement scheme 1 | Profit (loss) before income tax | 1,366,700 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 1,230,185 |
| Note: Labour costs | Employees | 21 |
| Note: Labour costs | Labour costs | 2,262,968 |
| Rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 1,286,474 |
Linked company
Company: Novo Nordisk Estonia OÜ